Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes

<div>Percentage of eyes that received 1, 2, or 3 DEX injections with regard to naïve status. The percentage of eyes progressively declined with increasing number of injections regardless of naïve status.</div>

Journal of Ophthalmology

fig2

Figure 2

Figure 2: Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes 

Figure 2 | Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes 